Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Net Cash Flow (2010 - 2026)

Exelixis (EXEL) posted quarterly Net Cash Flow of -$256.3 million for Q2 2026, down 662.41% year-over-year from $45.6 million in Q2 2025, and down 341.4% quarter-over-quarter from $106.2 million in Q1 2026.

Analysis

Exelixis (EXEL) Net Cash Flow (2010 - 2026) Analysis & Trends

Exelixis' Net Cash Flow history runs 17 years deep, the most recent figure standing at -$256.3 million for Q2 2026.

  • In Q2 2026, Net Cash Flow fell 662.41% year-over-year to -$256.3 million; the TTM figure through Apr 2026 stood at $42.4 million (up 155.93% YoY), while the FY2026 annual figure was $265.1 million, up 681.14% from the prior year.
  • Net Cash Flow for Q2 2026 stood at -$256.3 million, down from $106.2 million in the prior quarter.
  • The five-year high for Net Cash Flow was $211.9 million in Q4 2025, with the low at -$256.3 million in Q2 2026.
  • The 5-year median for Net Cash Flow is -$33.6 million (2025), against an average of -$25.7 million.
  • The sharpest annual moves came in 2025 and 2026: Net Cash Flow plunged 879.38% in 2025, then soared 359.17% in 2026.
  • Exelixis' Net Cash Flow stood at -$174.1 million in 2022, then grew by 23.11% to -$133.9 million in 2023, then jumped by 144.74% to $59.9 million in 2024, then soared by 253.78% to $211.9 million in 2025, then plunged by 220.99% to -$256.3 million in 2026.
  • Business Quant data shows EXEL's Net Cash Flow at -$256.3 million in Q2 2026, $106.2 million in Q1 2026, and $211.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 55.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 55.30 Mn
Apr 3, 2026 -256.34 Mn
Jan 2, 2026 106.19 Mn
Oct 3, 2025 211.87 Mn
Jul 4, 2025 -19.32 Mn
Apr 4, 2025 -33.62 Mn
Jan 3, 2025 -40.97 Mn
Sep 27, 2024 59.89 Mn
Jun 28, 2024 -61.10 Mn
Mar 29, 2024 -3.43 Mn
Dec 29, 2023 -133.87 Mn
Sep 29, 2023 -67.62 Mn
Jun 30, 2023 -77.60 Mn
Mar 31, 2023 39.40 Mn
Dec 30, 2022 -174.09 Mn
Sep 30, 2022 39.08 Mn
Jul 1, 2022 -99.59 Mn
Apr 1, 2022 73.39 Mn
Dec 31, 2021 65.40 Mn
Oct 1, 2021 59.19 Mn